News

AdvanDx said that the faster protocol reduces PNA Fish turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to

AFFiRiS said that the vaccine has undergone numerous preclinical tests which have confirmed its principle of action (Proof of Concept). The company is now starting to prepare for

The waiver is the monitoring technology that can be used in a broader range of clinical settings, such as labs that do not meet the requirements to do

The purpose of MOU is to continue to develop and expand a framework of cooperation between BBDC and Igen to implement a mutually beneficial program, whereby Igen will

In addition to treating burns and other acute wounds, ReCell will also target the growing demand for aesthetic surgery, scar revision and dermal treatments for the aging population.

Earlier, in September 2009, the World Health Organisation has entered into two sublicences, under its Global Pandemic Influenza Action Plan for developing countries, with the Government Pharmaceutical Organisation

Polidocanol is a sclerosant, an irritant injected to treat varicose veins. Polidocanol causes fibrosis inside varicose veins, occluding the lumen of the vessel and reducing the appearance of

As per the collaboration, which was originally signed in August 2009, the companies will leverage Silence’s proprietary siRNA molecules and multiple lipid delivery and targeting technologies to demonstrate

Reportedly, the samples were evaluated in different parameters like: brain plasticity, serotonin levels and behavioral function. These parameters were selected as important indicators of the effect needed to